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Shigella flexneri, the causative agent of shigellosis, is a gram-negative bacterial pathogen that initiates
infection by invading cells within the colonic epithelium. Contact with host cell surfaces induces a rapid burst
of protein secretion via the Shigella type III secretion system (TTSS). The first proteins secreted are IpaD, IpaB,
and IpaC, with IpaB and IpaC being inserted into the host cell membrane to form a pore for translocating late
effectors into the target cell cytoplasm. The resulting pathogen-host cross talk results in localized actin
polymerization, membrane ruffling, and, ultimately, pathogen entry. IpaD is essential for host cell invasion, but
its role in this process is just now coming to light. IpaD is a multifunctional protein that controls the secretion
and presentation of IpaB and IpaC at the pathogen-host interface. We show here that antibodies recognizing
the surface-exposed N terminus of IpaD neutralize Shigella’s ability to promote pore formation in erythrocyte
membranes. We further show that MxiH and IpaD colocalize on the bacterial surface. When TTSS needles were
sheared from the Shigella surface, IpaD was found at only the needle tips. Consistent with this, IpaD localized
to the exposed tips of needles that were still attached to the bacterium. Molecular analyses then showed that
the IpaD C terminus is required for this surface localization and function. Furthermore, mutations that prevent
IpaD surface localization also eliminate all IpaD-related functions. Thus, this study demonstrates that IpaD
localizes to the TTSA needle tip, where it functions to control the secretion and proper insertion of translocators into
host cell membranes.
Shigella flexneri is the causative agent of shigellosis, a severe
form of bacillary dysentery that is globally responsible for more
than 1.1 million deaths each year, especially among young
children (www.who.int/vaccine_research/diseases/shigella/en/).
S. flexneri is transmitted by the fecal-oral route, typically via
contaminated water, and is spread efficiently due to an unusu-
ally low 50% infective dose (13). After ingestion, acid-tolerant
S. flexneri passes through the stomach to the colonic mucosa,
where it is transcytosed across M cells into the underlying
gut-associated lymphoid tissues (29). There, the shigellae enter
macrophages and efficiently induce apoptosis, leading to the
eventual release of the pathogen on the basal side of the
colonic epithelium (46). The shigellae then invade these epi-
thelial cells by inducing major cytoskeletal rearrangements
(40). The internalized bacteria lyse the resulting vacuolar
membrane (33), replicate intracellularly, and move about the
cytoplasm via actin-based motility (1), which allows direct cell-
to-cell spreading (28).
The Shigella invasive phenotype genetically localizes to a
31-kb region of its large virulence plasmid, which includes
the genes for the type III secretion system (TTSS) (7, 34).
The mxi-spa operon encodes the type III secretion apparatus
(TTSA), and the ipa-ipg operon encodes the type III-secreted
protein effectors/translocators IpaA through IpaD and the cy-
toplasmic IpaB/IpaC chaperone IpgC. The TTSA is composed
of a basal body spanning both bacterial membranes and an
external needle (4). The TTSA needle, a polymer of MxiH, is 50
nm long and 7 nm in diameter with a central channel that is 2.5
nm in diameter (6). After TTSA assembly, secretion is largely
arrested until a stimulus such as host cell contact is received.
Currently, the mechanism for activation has not been determined,
although it is likely that the needle or proteins intimately associ-
ated with the needle are involved (16).
Upon receipt of a secretion signal, IpaB, IpaC, and IpaD,
which are all essential for bacterial entry, are transported
through the TTSA (23). IpaB and IpaC are inserted into the
host cell membrane to form a translocon pore through which
other effector proteins subsequently pass (2). Additionally,
IpaB and IpaC possess direct effector functions that alter host
cell physiology, including the induction of apoptosis in macro-
phages (45) and cytoskeletal rearrangements in epithelial cells
(17, 38, 39), respectively. The essential function of IpaD in the
invasion process has remained elusive.
IpaD was originally proposed to partner with IpaB to form
a plug within the TTSA because the deletion of either protein
results in the secretion of large amounts of the remaining
TTSS effectors in the absence of a secretion signal (22). Recent
findings suggest that IpaD’s role is more complex. Deletion
mutagenesis was used to show that the N-terminal third of
IpaD is partially dispensable for Shigella invasiveness (31).
These deletions had a relatively minor impact on invasiveness
and secretion control, but they substantially reduced contact
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hemolysis due, in part, to a slower rate of translocon insertion
into erythrocyte membranes (31). Conversely, deletions in the
C-terminal two-thirds of IpaD resulted in a complete loss of
invasion functions and secretion control. Deletions near the
C-terminal end of the protein resulted in massive uninduced
secretion of IpaB, IpaC, and IpaD (31). It thus appears that
IpaD is needed for secretion control and proper insertion of
translocators into host cell membranes.
The closest relative of IpaD is SipD from Salmonella, which
is 40% identical and 56% similar to IpaD, with the C terminus
being 73% identical and 98% similar (15). Like ipaD null
mutants, sipD null mutants are noninvasive and secrete large
amounts of the Salmonella translocators SipB and SipC (15).
BipD from Burkholderia pseudomallei is also strikingly similar
at the C terminus, with a bipD null mutant also being nonin-
vasive (36). Although there are no obvious IpaD homologs in
Yersinia spp. and Pseudomonas aeruginosa, LcrV and PcrV,
respectively, appear to share some functional homology. Null
mutants of lcrV and pcrV are unable to form translocons in host
cell membranes (9, 12, 20), while antibodies against LcrV and
PcrV have also been shown to prevent translocon insertion (10,
11). It was recently shown that LcrV localizes to the tip of the
Yersinia TTSS needle to form a tip complex (25). Previously,
Turbyfill et al. demonstrated that IpaD also localizes to the
Shigella surface (41). To more precisely define the surface
localization of IpaD, we have demonstrated that IpaD is local-
ized at the tip of purified Shigella TTSA needles via an inter-
action that is dependent upon the IpaD C terminus and, fur-
thermore, we show that anti-IpaD antibodies can prevent
Shigella contact-mediated hemolysis.
MATERIALS AND METHODS
Materials. The ipaA ipgD and ipaD (SF622) null mutants were from P. J.
Sansonetti (Institut Pasteur, Paris, France) (27). The mxiH null mutant was
generated by A. Allaoui (Brussels, Belgium) (3). Sheep red blood cells were from
Colorado Serum Company (Denver, CO). Protein A-Sepharose and TiterMax
adjuvant were from Sigma Chemical Co. (St. Louis, MO). Alexa Fluor secondary
antibodies were from Molecular Probes (Eugene, OR). Escherichia coli, pET15b,
and ligation mix were from Novagen (Madison, WI). Restriction enzymes were
from New England Biolabs (Beverly, MA). Oligonucleotide primers were from
IDT (Coralville, IA). Other chemicals were reagent grade.
Preparation of ipaD mutants for expression in SF622. pWPsf4D containing
the ipaD gene has been described previously (31). ipaD deletion mutants were
made by inverse PCR using pWPsf4D as a template, a primer composed of
GAGAGA, a BamHI restriction site, a stop codon, and 18 nucleotides flanking
the nucleotides to be deleted (the primer for pWPsf4D4E encoding IpaD329-332
was 5 GAGAGAGGATCCTCAAAGTTTATCTGTATCTGTACA, that for
pWPsf4D3E encoding IpaD330-332 was 5 GAGAGAGGATCCTCAAAAA
AGTTTATCTGTATCTGTA, and that for pWPsf4D2E encoding IpaD331-332
was 5 GAGAGAGGATCCTCAGAGAAAAAGTTTATCTGTATC) and a
primer encoding the 3 region up to and including the BamHI site of pWPsf4 (5
GAGAGAGGATCCTCTAGAGTCGA). The PCR product was digested with
BamHI, intramolecularly ligated, and transformed into E. coli NovaBlue. The
resulting plasmid was electroporated into S. flexneri SF622. Ampicillin selection
ensured the presence of the plasmid, while kanamycin resistance and/or Congo
red binding indicated the presence of the Shigella virulence plasmid.
Recombinant protein purification. D1-120/pET15b, which encodes IpaD1-120
was made by ligating the XhoI/BamHI fragment of pWPsf4D1112 into XhoI/
BamHI pET15b (31). D23E/pET15b, which encodes IpaD321-332, was made by
ligating the NdeI/BamHI fragment from pWPsf4D23E into pET15b (31). D26E/
pET15b, which encodes IpaD328-332, was made by ligating the NdeI/BamHI
fragment from pWPsf4D26E into pET15b (31). D21E/pET15b, which encodes
IpaD281-332, was made by ligating the NdeI/XhoI fragment from pWPsf4D2122
into pET15b (31). Tuner(DE3) E. coli was transformed with the resulting plas-
mid for high levels of protein expression. Recombinant proteins were purified by
nickel chelation chromatography as described previously (21).
Invasion and contact hemolysis. Contact-mediated hemolysis of sheep eryth-
rocytes has been described previously (30, 31). For the neutralization of Shigella-
induced contact-mediated hemolysis, the assay was modified as follows. Bacteria
(107 cells in 50 l of phosphate-buffered saline [PBS]) were combined with 50 l
of immunoglobulin G (IgG) and/or recombinant protein in PBS and allowed to
incubate at 37°C for 30 min. This mixture was combined with 50 l of washed
erythrocytes, and the assay was continued. S. flexneri invasion of Henle 407 cells
was monitored with a gentamicin-protection assay using an agarose/agar overlay
as previously described (30, 31). For the neutralization of invasion, bacteria
grown to mid-log phase were harvested by centrifugation and resuspended in
PBS. The bacteria were then incubated with 10 g IgG and/or 20 g recombinant
IpaD for 30 min prior to use in the invasion assays. To reduce exposure risks to
laboratory personnel, the ipaA ipgD null mutant was used (27). This strain is
deficient in IpaA and IpgD, proteins that are involved in the reorganization of
the host cell morphology. This strain has a wild-type phenotype for secretion
control, invasion, and hemolysis (27).
Uninduced and induced secretion of TTSS proteins. Uninduced secretion of
the TTSS is determined by measuring protein secretion by bacteria grown over-
night in tryptic soy broth (16, 23). Induced secretion is determined by measuring
protein secretion after the addition of Congo red, which causes a rapid burst of
protein secretion by the Shigella TTSS, thus mimicking the response seen upon
host cell contact (16). Both assays were used to determine the phenotype of the
IpaD mutants as described previously (16). Briefly, proteins from the clarified
overnight growth media were precipitated with 10% trichloroacetic acid, washed,
and resuspended in sodium dodecyl sulfate (SDS) sample buffer. Sample buffer
was added to a final concentration of 1 to the proteins from the clarified
induction media. For both induction states, proteins from equal amounts of
bacteria based on A600 were separated by SDS-polyacrylamide gel electrophore-
sis and transferred to nitrocellulose, and IpaB, IpaC, and IpaD were detected by
using mouse monoclonal antibodies followed by Alexa Fluor 680 goat anti-mouse
IgG (Molecular Probes, Eugene, OR). Western blot images were obtained using
an Odyssey infrared imager (LI-COR, Lincoln, NE).
Rabbit anti-MxiH antibody production and other antisera. The preparation of
recombinant MxiH has been described previously (8). New Zealand White rab-
bits were immunized intramuscularly with 50 g of MxiH four times at 2-week
intervals with complete Freund’s adjuvant or TiterMax, and incomplete Freund’s
adjuvant was used on the first and second immunizations. Blood was collected 11
days after the final immunization and tested by enzyme-linked immunosorbent
assay against MxiH as previously described (41). Enzyme-linked immunosorbent
assay titers ranged from 6,400 to 25,600. Shigella polyclonal and monoclonal
antibodies to IpaB, IpaC, and IpaD have been previously described (24, 41).
Purification of IgG. One milliter of rabbit serum was passed over 0.5 ml of
PBS-equilibrated protein A-Sepharose. The resin was washed with PBS, and the
IgG was eluted with 0.1 M glycine-HCl, pH 3.0. IgG was dialyzed against PBS
and stored at 20°C. Protein concentrations were determined by UV absorbance
using an extinction coefficient of 0.724 mg/A280.
Confocal microscopy. Shigella were grown at 37°C in tryptic soy broth to
mid-log phase, collected by centrifugation, and resuspended in 4% formaldehyde
in PBS. The bacteria were fixed to the slide, blocked with 1% bovine serum
albumin, and treated with the mouse monoclonal anti-IpaD antibody (16F8),
followed by Alexa Fluor 488 goat anti-mouse IgG or rabbit anti-MxiH (R73),
anti-IpaB (R69), or anti-IpaC (R64) antibody, followed by Alexa Fluor 568 goat
anti-rabbit IgG. Imaging was performed using a Zeiss Meta 510 laser scanning
confocal microscope, alternately using either the 477-nm laser line and a 505 to
530 band-pass emission filter (Alexa 488) or the 543-nm laser line with a 580-nm
long-pass emission filter (Alexa 568). Transmission images were also obtained.
Electron microscopy. When mxiH is subcloned behind the inducible lac pro-
moter in pRK2 and protein expression is induced in a mxiH null mutant (mxiH/
pRK2//SH116), long needles greater than 300 nm are made (16, 37). This strain
was grown to mid-log phase in tryptic soy broth containing 100 g/ml ampicillin,
50 g/ml kanamycin, and 1 mM IPTG (isopropyl--D-thiogalactopyranoside) at
37°C. Cells were harvested by centrifugation, resuspended in 4% formaldehyde
in PBS, collected by centrifugation, and resuspended in cold PBS at 1/30 of the
original culture volume. The needles were sheared by passing the cell suspension
once through an 18-gauge needle. After removal of the bacterial cells by cen-
trifugation, the supernatant containing the sheared needles was clarified twice by
centrifugation at 15,000  g. The needles were precipitated by the addition of
polyethylene glycol 6000 and NaCl to 2% and 0.1 M, respectively. After 20 min
on ice, needles were collected by centrifugation at 10,000  g and resuspended
in minimal Tris-buffered saline. The needle sample was diluted, applied to
carbon/Formvar-coated copper grids, and treated with anti-IpaD rabbit IgG
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followed by 5 nm gold-labeled goat anti-rabbit IgG (Nanogold, Yaphank, NY).
Negative staining with 2% uranyl acetate permitted the visualization of the
purified needles. A similar procedure was used to stain IpaD associated with
needles on intact Shigella isolates. In this case, mid-log phase bacteria were
harvested and resuspended in PBS at 1/10 the original culture volume before
being applied to grids. Grids were imaged using a JEOL 1200-EX II transmission
electron microscope at an electron acceleration voltage of 120 KeV.
Far-UV circular dichroism spectroscopy. Far-UV circular dichroism (CD)
spectra were collected using a Jasco J-720 spectropolarimeter equipped with a
Peltier temperature controller (Jasco, Inc., Easton, MD). The spectra were
acquired using a 0.1-cm-path-length cuvette at 10°C. A resolution of 0.5 nm and
a scanning speed of 20 nm/min with a 2-s response time were employed. Spectra
presented are averages of three consecutive measurements. Secondary structure
content was estimated using the Dichroweb software package (18, 43), which
allows the analysis of secondary structure content using the algorithms CONTIN
(35), SELCON (32), and CDSSTR (19). The thermal unfolding of the proteins
was followed by monitoring the ellipticity at 222 nm over a temperature range of
10 to 90°C with a resolution of 0.5°C and 15°C/h heating rate. Protein concen-
tration was 0.1 mg/ml. CD signals were converted to mean residue molar ellip-
ticities, [	]R, and the thermal transitions were analyzed using the Jasco spectral
manager and Microcal Origin 6.0 software (17).
RESULTS
Neutralization of contact-mediated hemolysis by anti-IpaD
antibodies. It was recently demonstrated by Goure et al. that
anti-PcrV antibodies protected erythrocytes from hemolysis by
P. aeruginosa by preventing membrane insertion of the TTSS
translocon (11). Contact-mediated hemolysis is also the assay
for assessing IpaB/IpaC translocon insertion into erythrocytes
by Shigella (2, 31). To determine whether anti-IpaD antibodies
could also block erythrocyte lysis, S. flexneri was incubated with
anti-IpaD rabbit IgG and used in a standard contact-mediated
hemolysis assay (Fig. 1A). At 25 ng/l, rabbit anti-IpaD IgG
(R63) (41) neutralized contact-mediated hemolysis by more
than 50%, while 100 ng/l reduced it by over 75%. In contrast,
rabbit anti-IpaC IgG (R64) had no effect (Fig. 1A). The anti-
IpaD antisera were raised against recombinant IpaD (rIpaD)
and recognize epitopes throughout IpaD, including six surface-
exposed epitopes within the N-terminal 120 amino acids (41).
In contrast, antibodies raised against a peptide containing res-
idues 280 to 295 from the IpaD C terminus (R23) that did not
detect IpaD at the Shigella surface (41) did not neutralize S.
flexneri contact hemolysis (Fig. 1A).
The specificity of the anti-IpaD IgG in protecting erythro-
cytes from S. flexneri-induced lysis was tested by adding rIpaD
as a competitor for antibody binding. The addition of as little
as 50 ng of rIpaD restored complete erythrocyte lysis (Fig. 1B).
Similarly, when the C-terminal deletion mutant rIpaD281-332
was used as competitor, lysis was restored. Conversely, when
the N-terminal deletion mutant rIpaD1-120 was tested as an
antibody binding competitor, it provided no reversal of the
protection from hemolysis offered by the IpaD antibodies, sug-
gesting that the neutralizing antibodies recognize a region
within residues 1 to 120. Spectral analysis by circular dichroism
demonstrated that rIpaD1-120 retains all of its secondary
structure and thermal stability (M. Espina et al., submitted for
publication) and, thus, appears to be folded correctly. There-
fore, the inability of rIpaD1-120 to competitively inhibit R63-
mediated neutralization of hemolysis is not an artifact of pro-
tein misfolding. Taken together, the data suggest that the
surface-exposed N-terminal region of IpaD is critical for trans-
locon insertion.
Previously, it was shown that deletions within the N-terminal
region have a greater effect on hemolysis than on invasion (31).
To determine whether the rabbit anti-IpaD IgG (R63) could
impact invasion, a standard gentamicin-protection assay was
performed. The anti-IpaD IgG neutralized invasion to 57% 

12% of that of wild-type Shigella, which could be restored
(118% 
 11%) by the addition of rIpaD as a competitor for
antibody binding. These data suggest that these antibodies can
neutralize both invasion and contact hemolysis.
IpaD is found on the Shigella cell surface and localizes to the
tip of the TTSA needle. The localization of IpaD to the Shigella
cell surface was initially examined using immunofluorescence
confocal microscopy. After labeling with rabbit anti-IpaD an-
tibodies and Alexa Fluor 568-conjugated goat anti-rabbit IgG
(Fig. 2A and E), a punctate zone staining pattern was seen on
the bacterial surface. A similar pattern for LcrV staining on the
Yersinia surface was seen by Fields et al. (9). Rabbit anti-MxiH
antibodies were then used to detect surface-exposed Shigella
TTSA needles. A similar punctate zone staining pattern was
seen for the anti-MxiH antibodies (Fig. 2B and F). Staining by
anti-IpaD antibodies was not seen on either an ipaD (Fig. 2C
and G) or an mxiH null mutant (Fig. 2D and H). When S.
flexneri isolates were examined for surface-exposed IpaB or
FIG. 1. Neutralization of contact hemolysis by anti-IpaD antibod-
ies. (A) Rabbit anti-IpaD IgG (F), rabbit anti-IpaD280-295 IgG (E), and
rabbit anti-IpaC IgG () were incubated with bacteria for 30 min prior
to a standard contact-mediated hemolysis assay (31). (B) Lysis was
restored by competitive titration of rIpaD (F) and IpaD281-332 () but
not rIpaD1-120 (E) into the bacteria/rabbit anti-IpaD IgG (50 ng)
mixture. Contact hemolysis is presented as values relative to the he-
molysis caused by the Shigella ipaA ipgD null mutant, which has been
assigned a value of 100% 
 standard deviation (SD) (n  3). Error
bars indicate standard deviations.
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IpaC, anti-IpaB staining was seen in only about 1% of the
bacteria and no anti-IpaC staining was seen (data not shown).
Thus, IpaD is present on the bacterial surface prior to host cell
contact, while IpaB and IpaC are not. Western blot analysis
indicates that both IpaD and IpaB are present in long needles
sheared from the surface of Shigella; however, IpaB was not
detected as being surface exposed on the uninduced bacteria
by any of the antibodies tested (data not shown). In contrast,
IpaC was not even found associated with the sheared needles.
Because IpaD and MxiH displayed similar staining patterns
on the Shigella surface, bacteria were double labeled with anti-
IpaD monoclonal antibodies and rabbit anti-MxiH antibodies.
Secondary labeling with Alexa Fluor 488-conjugated goat anti-
mouse IgG and Alexa 568 goat anti-rabbit IgG then allowed
the visualization of IpaD and MxiH independently on the same
bacterium (Fig. 3). When the images were merged, it appeared
that IpaD and MxiH were colocalized (Fig. 3D). Although
MxiH labeling can occasionally be seen without IpaD labeling
(data not shown), no IpaD labeling is seen without concomi-
tant MxiH staining (Fig. 3). These data suggested that surface-
localized IpaD is associated with the MxiH needle of the Shi-
gella TTSS prior to secretion induction. Recent findings by
Mueller et al. (25) further strengthened the argument that
IpaD may be localized to the tip of the Shigella TTSA needle.
To determine whether IpaD is localized at the TTSA needle
tip, immunogold labeling, coupled with transmission electron
microscopy, was used. Shigella isolates were harvested and
used directly for immunogold labeling of any IpaD associated
with the bacterial surface. It was found that immunogold la-
beling occurred at only the distal tip of MxiH needles that were
associated with the bacteria (Fig. 4A and C). To obtain more
detailed images (Fig. 4D), needles were sheared from the mxiH
null mutant complemented with mxiH/pRK2 (mxiH/pRK2//
SH116) (16). Because the mxiH gene in the pRK2 plasmid is
under the control of lac promoter, the addition of IPTG is
required for protein expression and the restoration of all vir-
ulence functions. The needles formed in this strain, however,
can be 300 nm or more in length rather than the typical 50-
FIG. 2. Presentation of IpaD at the Shigella cell surface. For surface localization of IpaD and MxiH, S. flexneri was treated with anti-IpaD mouse
monoclonal antibodies/Alexa Fluor 488-conjugated goat anti-mouse IgG (E) or rabbit anti-MxiH antibodies/Alexa Fluor 568-conjugated goat anti-rabbit
IgG (F). When an ipaD null mutant (G) or a mxiH null mutant (H) was treated with anti-IpaD antibody/Alexa Fluor 488-conjugated goat anti-mouse
IgG, no IpaD was visualized on the cell surface. Panels A to D are differential interference contrast micrographs of panels E to H, respectively.
FIG. 3. Colocalization of IpaD and MxiH on the Shigella surface.
Double labeling of S. flexneri with anti-IpaD monoclonal antibodies/Alexa
Fluor 488-conjugated goat anti-mouse IgG and anti-MxiH rabbit antibodies/
Alexa Fluor 568-conjugated goat anti-rabbit IgG. Panel A shows the differ-
ential interference contrast image of the bacteria. Panel B (green pseudo-
colored image) indicates IpaD labeling. Panel C (red pseudo-colored image)
indicates MxiH. Panel D is the merged image. Arrows illustrate that IpaD
labeling occurs only where there is also MxiH labeling.
4394 ESPINA ET AL. INFECT. IMMUN.









nm-long needles of wild-type strains (Fig. 4D). These long
needles are more readily sheared from the Shigella surface for
individual examination (16). After formaldehyde treatment,
long needles were sheared from the surface of mxiH/pRK2/
SH116 and purified. IpaD was seen at the tip of these needles
by immunogold labeling (Fig. 4C), while no IpaD staining
could be seen for needles prepared from the ipaD null mutant
SF622 (data not shown). Gold labeling of IpaD is asymmetric,
being observed at only one end of the sheared needles, dem-
onstrating that IpaD resides at only the exposed tip of the
MxiH needle. It should be noted that TTSA needles do not
easily shear from the Shigella surface unless mxiH is overex-
pressed to allow long-needle formation. This is presumably
due to the base of the needle being protected within the O-
polysaccharide layer of the Shigella surface lipopolysaccharide,
which has been shown to impact type III secretion (42), and is
why Yersinia needles must have a minimum length to make
host cell contact (14). Because the base of the MxiH needle is
protected from shearing, the polar localization of IpaD on the
sheared needles represents the needle tip and not the base.
The localization of IpaD on the needle tips is corroborated by
the images in Fig. 4A and C. Moreover, no needle fragments
had IpaD at both ends and some, presumably broken internal
fragments, failed to have IpaD at either end, further indicating
that the observed IpaD is located at only the exposed tip of the
needle.
The IpaD C terminus is required for surface localization.
Previous deletion mutagenesis suggested that the IpaD N ter-
minus (residues 1 to 120) is required for efficient translocon
insertion into target cell membranes, while the IpaD C termi-
nus (residues 120 to 332) participates in protein folding and
TTSS secretion control (31). To correlate IpaD localization at
the needle tip with secretion control, Shigella isolates making
different IpaD deletion mutants were probed with anti-IpaD
FIG. 4. Transmission electron micrograph of immunogold-labeled IpaD at the tip of negatively stained needles. (A) Shigella isolates were grown
to mid-log phase, harvested, and applied to carbon/Formvar-coated copper grids. They were then treated with rabbit anti-IpaD IgG and detected
with 5 nm gold-labeled goat anti-rabbit IgG. Uranyl acetate (2%) was used for negative staining. (B) Needles were sheared from the Shigella,
applied to carbon/Formvar-coated copper grids and treated as described above for panel A. (C) The Shigella strain mxiH/pRK2/SH116, which
makes long needle, was treated as described for panel A. (D) Long needles (300 nm) were sheared from mxiH/pRK2/SH116 and treated as
described above for panel A. Magnification, 120,000.
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rabbit antibodies/Alexa Fluor 568 goat anti-rabbit IgG and
assessed for surface-exposed IpaD via immunofluorescence
microscopy. The N-terminal deletion mutants IpaD41-80
and IpaD81-120 were largely surface localized with 94 and
88% of the bacteria being stained, respectively. In contrast,
only 1% of the bacteria making IpaD161-200 were stained.
These results were expected because large deletions (40
residues) between residues 120 to 320 appear to give rise to
an unstable form of IpaD (data not shown) that is unable to
complement SF622 (31).
We have previously shown that IpaD’s C-terminal tail is
critical for invasion functions and that deleting only five resi-
dues from its C terminus abolishes invasion, contact hemolysis,
and secretion control (31). These IpaD C-terminal deletion
mutants also failed to present IpaD on the bacterial surface.
Less than 10% of the bacteria making the five-amino-acid
deletion (IpaD328-332) had IpaD on their surfaces. Because
the C-terminal deletion mutants secrete large amounts of
IpaD, these results show that the IpaD surface staining of
wild-type bacteria and other mutants is not a result of random
cross-linking of secreted IpaD to the needle during the staining
process.
When IpaD mutants with C-terminal deletions of two, three,
or four amino acids were examined, the proportion of bacteria
staining with anti-IpaD antibodies was significantly greater for
IpaD331-332 than that for IpaD with three or four residue
deletions (Table 1). Correspondingly, the ability of smaller
IpaD deletion mutants to complement invasion and contact
hemolysis was also enhanced as the deletion became smaller
(Table 1). Wild-type invasion levels were seen with IpaD331-
332. The control of secretion, both uninduced and induced,
strengthened with the addition of each amino acid (Fig. 5).
Large deletions within the C-terminal two-thirds of IpaD
result in misfolding of the protein, which could easily account
for the failure of the protein to localize at the Shigella cell
surface (M. Espina et al., submitted for publication). This is
not presumed to be the case, however, for small deletions at
the immediate C terminus of IpaD. To test for proper protein
folding, two of the C-terminal mutant proteins, IpaD321-332
and IpaD328-332, were purified and examined by CD spectros-
copy to determine the effect of the deletions or addition on the
secondary structure of the mutant proteins (Fig. 6A and Table
2). The CD spectra of IpaD and the short IpaD C-terminal
deletion mutants showed similar double minima at 208 nm and
222 nm, suggesting a significant amount of helical structure as
predicted by the in silico analysis of IpaD. The secondary
structure content was estimated from the far-UV CD spectra
using CDSSTR (19) (Table 2). No major changes were ob-
served in the distribution of secondary structure of the IpaD
deletion mutants (Table 2). Of the proteins tested, IpaD328-
332 showed the greatest change in estimated secondary struc-
ture content.
The relative thermal stabilities of the IpaD mutants were
then determined by monitoring the changes in the ellipticity at
222 nm as a function of temperature (Fig. 6B). IpaD and
IpaD328-332 displayed major thermal transitions at about 60
and 80°C (Fig. 6B). The 12-residue deletion at the IpaD C
FIG. 5. Analysis of uninduced and induced secretion of IpaD mu-
tants. SF622, the ipaD null mutant, and SF622 transformed with a
plasmid expressing either wild-type IpaD or one of the deletion mu-
tants were analyzed for their abilities to secrete IpaB, IpaC, and IpaD.
Supernatants from either bacterial cultures grown overnight (A) or
bacteria induced to secrete by the addition of Congo red (B) were
analyzed by Western blot analysis using mouse monoclonal anti-IpaB,
anti-IpaC, and anti-IpaD antibodies with Alexa 680 goat anti-mouse
antibodies (Molecular Probes, Eugene, OR). Western blot images
were obtained using an Odyssey infrared imager (LI-COR, Lincoln,
NE). In panel A, the lanes between SF622 and 329-332 were not
relevant for this study and were deleted.
TABLE 1. Phenotype of IpaD C-terminal deletion mutants
IpaD straina Bacteria withexposed IpaDb Invasion
c Hemolysisd
SF622 0 
 0 0 
 0 0 
 0
IpaD 97.80 
 0.51 100 
 10e 100 
 14 f
IpaD328-332 0 
 0.0 0.1 
 0g 0 
 0g
IpaD329-332 10.42 
 1.73 16 
 7 8 
 3
IpaD330-332 47.19 
 1.93 56 
 21 27 
 10
IpaD331-332 77.21 
 6.94 110 
 10 100 
 15
a SF622 is the ipaD null mutant. All other strains are SF622 transformed with
the plasmid encoding either wild-type IpaD or one of the C-terminal deletion
mutants.
b Percentage of cells with surface-exposed IpaD as determined by immuno-
fluorescence microscopy. At least 100 bacteria in each of three randomly selected
fields were counted (n  3).
c Invasion is relative to IpaD (pWPsf4D/SF622) 
 SD (n  3) and is expressed
as a percentage of the control.
d Contact-mediated hemolysis is relative to IpaD (pWPsf4D/SF622) 
 SD
(n  5) and is expressed as a percentage of the control.
e Raw value of invasion of Henle cells by pWPsf4D/SF622 is 207 
 27 colonies.
f Raw value of contact-mediated hemolysis of pwPsf4D/SF622 is 3.5 
 0.14
(A545).
g Value is from reference 31.
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terminus, IpaD321-332, exhibited a broader change at the onset
temperature, suggesting that it might experience greater struc-
tural perturbation than the full-length protein (Fig. 6B). These
results show that small deletions (no more than five residues)
or additions at the IpaD C terminus do not have a major
impact on its folding or thermal stability. It is therefore likely
that the defect in surface localization for IpaD possessing small
C-terminal deletions is not a problem with protein structure.
The most likely problem with these IpaD mutants thus appears
to be the elimination of a region that is necessary for protein-
protein interactions at the needle tip.
IpaD localization at the cell surface of mxiH mutant strains.
Kenjale et al. produced 46 mutations spanning MxiH and dem-
onstrated that these mutations either have no specific effect on
Shigella virulence properties or fall into five distinct classes,
ranging from severe defects that abolish needle polymerization
to mild defects that prevent effector secretion (16). These 46
strains were examined for IpaD surface localization (Table 3).
Interestingly, only six of these strains failed to exhibit IpaD on
their cell surfaces. None of these mutants are capable of in-
vading cultured cells. Three of these strains cannot polymerize
needles due to deletions of three, four, or five residues from
the C terminus of MxiH. Additionally, IpaD was not detected
on the surfaces of S. flexneri with MxiH mutation W10A or
K72A or the double mutation P44A/Q51A. The W10A mutant
produces short needles, suggesting a polymerization defect
that might be unable to localize IpaD to the surface. It is
postulated that W10A would prevent required contacts be-
tween MxiH monomers and thus inhibit packing and needle
formation (J. E. Deane et al., submitted for publication). K72A
is also defective in needle polymerization as well as in the
secretion of effectors. Like W10, K72 is predicted to be nec-
essary for contact with an adjacent MxiH monomer within the
needle and, therefore, is required for needle polymerization
(Deane et al., submitted). Not all mutations that impact needle
polymerization affected IpaD surface localization. Y57A, for
example, is one of nine MxiH mutations that also cause needle
polymerization defects, yet IpaD was found to be surface lo-
calized in this strain as well as in the other eight polymerization
defective mutants. The P44A/Q51A double mutant, however,
is unique among the six strains that cannot surface localize
IpaD. This double mutant does not have a needle polymeriza-
tion defect, but it is noninducible with Congo red (16). P44 and
Q51 are postulated to map to the outside of the packed needle
rather than being involved in monomer-monomer interactions
(Deane et al., submitted). Further studies will need to be
initiated to understand the impact that these particular MxiH
mutations have on the inability to localize IpaD to the surface.
Thus, the mutations in MxiH that completely prevent needle
formation also prevent IpaD surface localization. But, of the
remaining mutant MxiH phenotypes, the vast majority are still
able to maintain IpaD at the tip. Therefore, a direct correla-
tion between needle packing or secretion defects and the in-
ability to localize IpaD to the surface of uninduced bacteria
cannot be made.
DISCUSSION
Previous studies have clearly identified IpaD as an essential
virulence factor for Shigella (23). The precise role that IpaD
plays in virulence, however, has remained enigmatic. The data
FIG. 6. Secondary structure analysis of IpaD and IpaD mutants by
CD. (A) CD spectra were collected at 10°C at a rate of 20 nm/min
employing a resolution of 0.5 nm and are an average of three consec-
utive measurements. Protein concentrations were 0.1 mg/ml in PBS.
The double minima shown are indicative of a highly -helical protein.
(B) Temperature dependence of the molar ellipticity at 222 nm was
monitored from 10 to 90°C at 0.5°C intervals at a rate of 15°C/h.
Protein concentrations were 0.1 mg/ml in PBS. Although the error bars
have been omitted for clarity, the individual data entries have a typical
uncertainty of 5% or less (n  3).
TABLE 2. Secondary structure estimates for IpaD
and IpaD mutants
% Contenta
Protein -Helix -Sheet Turn Random
IpaD 55b 10 12 22.5
IpaD321-332 61 12 8 18.5
IpaD328-332 66 5 8 20
a The estimated percent content of each type of secondary structure is pro-
vided.
b Secondary structure contents are estimated to be 
 3%.
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presented here demonstrate that IpaD localizes to the tip of
the Shigella TTSA needle prior to the induction of type III
secretion and that proper localization of IpaD to the surface is
a prerequisite for cellular invasion and is very likely necessary
for the proper insertion of the IpaB/IpaC translocon into the
host cell membrane. Previously, we have shown that the dele-
tion of a significant portion of the IpaD N terminus (residues
1 to 120) has little impact on invasion but results in lowered
hemolysis due to a slower rate of translocon insertion into
target cells (31). In contrast, the IpaD C terminus (residues 121
to 332) is essential for IpaD function since large deletions
within this region abolish secretion control, invasion, and con-
tact hemolysis (31). The localization of IpaD to the bacterial
surface appears to correlate with these observed virulence phe-
notypes. N terminus deletion mutants were found to be surface
localized, while none of the large C-terminal deletion mutants
were visible on the bacteria. In fact, deletions greater than two
or three residues at the C terminus result in a dramatic de-
crease in IpaD present on the Shigella surface (Table 1). CD
spectroscopy demonstrates that the secondary structures of
these deletion mutants have not been significantly altered.
Thus, compromised structural integrity is not likely to be re-
sponsible for the inability of these proteins to function.
This is the first demonstration that members of the “IpaD
protein family,” which includes SipD of Salmonella typhi-
murium serovar Typhimurium and BipD of Burkholderia
pseudomallei, localize to the tip of the TTSA needle. IpaD,
SipD, and BipD have substantial sequence homology, espe-
cially within their C-terminal halves, suggesting functional con-
servation for this region (15) (the ClustalW program; data not
shown). Like ipaD, the sipD and bipD null mutants are nonin-
vasive, with the sipD-null mutant also demonstrating uncon-
trolled translocator secretion (15, 36). Recently, LcrV was
found to form a complex at the tip of the Yersinia TTSA needle
(25). Furthermore, PcrV and AcrV from Pseudomonas aerugi-
nosa and Aeromonas salmonicida, respectively, complemented
the lcrV null mutant to form a similar tip complex (25). As with
the IpaD homologs, the LcrV orthologs show amino acid sim-
ilarity, especially at their C termini (26). Unlike the LcrV
orthologs, which are interchangeable, however, the IpaD ho-
mologs are unable to restore virulence functions to an ipaD
null mutant (data not shown) (31). It is not yet known whether
the IpaD homologs may be able to localize to the MxiH needle
tip but are unable to control secretion.
When LcrV and IpaD are compared, the sequence homol-
ogy that is seen at the C terminus within either set of homologs
is not evident. Nevertheless, because IpaD, LcrV, and several
of their homologs all appear to control translocon insertion or,
at the very least, translocator secretion, it is intriguing to spec-
ulate that IpaD and LcrV homologs will all localize to the
needle tip to form the link between the needle and the trans-
locon. Mueller et al. were able to cross-link sheared needles to
demonstrate an interaction between LcrV and YscF (25). Due
to the differences in the bacterial systems, needles can be
efficiently sheared from the Shigella surface only if the mxiH is
overexpressed to form long needles (16). The fraction of IpaD
in this macromolecular structure now becomes even smaller
than that of the wild-type-length needles. Thus, when the nee-
dles are separated by SDS-polyacrylamide gel electrophoresis
and subjected to Western blot analysis, it is possible to visual-
ize a weak IpaD band. When the needles are cross-linked,
however, the MxiH ladder can be visualized but the IpaD
cannot, presumably because the small amount of IpaD is dis-
tributed among the many MxiH ladder bands. Although we
believe that, as with YscF-LcrV, there is a direct interaction
between IpaD and MxiH, we have thus far been unable to
establish this in vivo, though the data presented in Table 3 hint
that this is the case.
These studies also demonstrate that antibodies to IpaD can
protect erythrocytes from contact-mediated lysis by S. flexneri,
suggesting that they can neutralize IpaD-dependent presenta-
tion of IpaB/IpaC translocons to target cell membranes. Pre-
viously, the N-terminal 120 amino acids of IpaD were shown by
Turbyfill et al. to be accessible to antibodies and, therefore,
surface-exposed on the bacterium (41). Because IpaD1-120
was unable to compete with the anti-IpaD IgG to restore
erythrocyte lysis, it appears that the neutralizing epitopes may
lie within the first 120 residues of IpaD. LcrV and PcrV are
TABLE 3. IpaD surface localization on Shigella-expressing mutant forms of MxiHa
Mutation class Mutants in class Mutants notdisplaying IpaD
mxiH null mutant mxiH null
Wild-type-like MxiH, S2A, V3A, N7A, D8A, T11A, S13A, S14A, L15A, S16A,
E17A, V74A
Class I needle polymerization 3, 4, 5, W10A, Y57A 3, 4, 5, W10A
Class II needle length regulation defects K69A, I71A, K72A, D73A, D75A, I78A, I79A, Q80A, R83A K72A
Class III constitutive “on” secretion P44A, Q51A, 4 loop mutants
Class IV constitutive “uninducible” secretion D73A, P44A/Q51A P44A/Q51A
Class V “effector” secretion K69A, K72A, R83A K72A
No specific phenotype assigned T4A, V5A, P6A, L12A, L54A, T67A, V68A, V70A, N81A, F82A
a Surface localization of IpaD was determined by immunofluorescence using rabbit anti-IpaD antibodies. A complete description of these strains can be found in
reference 16.
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also known as protective or V antigens because antibodies
against them protect cultured cells and model animals from
Y. pestis and P. aeruginosa infections, respectively (10, 44).
Similar protective effects were shown for anti-AcrV antibodies
(5). The protective nature of the LcrV and PcrV can now be
attributed to their prominent location atop the TTSA needles.
We here show that this phenomenon may also occur for IpaD,
since antibodies that target the IpaD N terminus protect eryth-
rocytes from Shigella-induced lysis.
IpaD and IpaB have been proposed to interact to form a
plug that prevents uncontrolled secretion (22). In this study,
within the context of uninduced Shigella, IpaD was surface
localized, while IpaB could be found associated with the
sheared needles by only Western blot analysis (data not
shown). IpaC was not seen associated with the uninduced nee-
dles (data not shown). Thus, this study demonstrates that IpaD
is the first of the three Shigella virulence proteins involved in
translocon formation to be secreted to a position at the needle
tip, while, based on its location within the needle, IpaB is
probably the second. Based on previous work and this study,
we present the following working model. Upon the completion
of needle polymerization, IpaD enters the needle channel and
takes up a position at the tip of the needle. Based on the
requirement for the C terminus to maintain IpaD atop the
needle and the inability to detect surface-exposed epitopes
within this region, the C terminus of IpaD is likely to lie
beneath the main body of the protein or perhaps even be
buried within the secretion channel itself. The IpaD C termi-
nus may actually interact with MxiH or, alternatively, IpaB
located within the channel. Biophysical characterization of
IpaD has revealed the presence of an intramolecular coiled
coil that is predicted to involve residues 130 to 174 and 270 to
315 (Espina et al., submitted). Thus, this structure would ex-
tend away from the needle and position the N-terminal domain
back toward the needle. Although we do not have in vivo data
demonstrating a direct interaction between IpaD and MxiH,
our model suggests that IpaD may maintain its position at the
needle tip via such an interaction. Meanwhile, because the
N-terminal epitopes have been shown to be surface exposed
and antibodies to these epitopes appear to be neutralizing, it is
likely that the 120 residues of the N terminus must lie outside
the needle-tip complex. Upon the interaction with a physio-
logical signal in the gut, which perhaps is sensed by the struc-
turally dynamic N-terminal domain (Espina et al., submitted),
a conformational change occurs within IpaD to allow IpaB,
which has been waiting in queue within the needle secretion
channel, to take a position at the needle tip with IpaD.
Whether this secretion signal is environmental and prior to
host cell contact or whether it actually is host cell contact is not
yet known. Once host cell contact is made, however, IpaC is
released to complete the needle-translocon conduit. There-
fore, in an ipaD null mutant, IpaD is not present at the tip of
the needle to maintain IpaB within the needle and, subse-
quently, atop the needle, thereby allowing the cytoplasmic Ipa
stores to be released in an uncontrolled fashion (22). More
work will need to be done to explain the phenotype of the ipaB
null mutant, but the loss of secretion control by these mutants
suggests that IpaD also has a role in maintaining the IpaD
“off” conformation. ipaB null mutants continue to have IpaD
located on the bacterial surface.
Taken together, the results presented here show that IpaD is
located at the tip of the Shigella TTSA needle by interactions
involving the IpaD C terminus. Because it is the most distal
component of the TTSA, IpaD may be involved in sensing host
cell contact and triggering the first step in translocon secretion
and insertion. From this position, IpaD has a central mecha-
nistic role in Shigella invasiveness and may be a potential target
for therapeutic intervention in the prevention of shigellosis.
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